Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

LABLAB
Showing 8 of 10 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in STANDARD BIOTOOLS INC

VIKING GLOBAL INVESTORS LP holds 58.7M shares of LAB (STANDARD BIOTOOLS INC), worth $48.3M as of 2026-Q2. LAB represents 0.1% of VIKING GLOBAL INVESTORS LP's portfolio.

Current Value

$48.3M

Current Shares

58.7M

Total Value Change

-$64.9M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
58.7M
0.0%
$48.3M0.1%$0.82
0
2026-Q1
Unchanged
58.7M
0.0%
$53.9M0.2%$1.04
0
2025-Q4
Unchanged
58.7M
0.0%
$75.1M0.2%$1.25
0
2025-Q3
Unchanged
58.7M
0.0%
$76.2M0.2%$1.27
0
2025-Q2
Unchanged
58.7M
0.0%
$70.4M0.2%$1.19
0
2025-Q1
Unchanged
58.7M
0.0%
$63.3M0.2%$1.14
0
2024-Q4
Unchanged
58.7M
0.0%
$102.6M0.3%$1.77
0
2024-Q3
Unchanged
58.7M
0.0%
$113.2M0.4%$1.92
0

Other major holders of LAB: BNP PARIBAS FINANCIAL MARKETS, PRIMECAP MANAGEMENT CO/CA/, Russell Investments Group, Ltd., Neuberger Berman Group LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used